Effect of pravastatin on proteinuria in patients with well-controlled hypertension

Hypertension

Volumn 40, Issue 1, 2002, Pages 67-73

  Lee, Tsung Ming ^a   Su, Sheng Fang ^b   Tsai, Chang Her ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

Angiotensin II; Endothelin 1; Hypertension, chronic; Proteinuria; Receptors; Statins

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ENDOTHELIN 1; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IMMUNOGLOBULIN G; LOSARTAN; PRAVASTATIN; RETINOL BINDING PROTEIN;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE CLEARANCE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HUMAN; HYPERTENSION; KIDNEY TUBULE FUNCTION; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; PRIORITY JOURNAL; PROTEIN URINE LEVEL; PROTEINURIA; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; URINARY EXCRETION;

ADULT; DOUBLE-BLIND METHOD; ENDOTHELIN-1; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERTENSION; LIPIDS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PRAVASTATIN; PROSPECTIVE STUDIES; PROTEINURIA; TREATMENT OUTCOME;

EID: 0036311314     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.0000022805.11288.7F     Document Type: Article

References (38)

1. Blood pressure control, proteinuria, and the progression of renal disease: The Modification of Diet in Renal Disease Study
2. Does essential hypertension cause end-stage renal disease?
3. Does an adequate control of blood pressure protect the kidney in essential hypertension?
4. Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease
5. Renoprotective effects of angiotensin II receptor blockade in type 1 diabetic patients with diabetic nephropathy
6. Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels
7. Lovastatin inhibits transforming growth factor-β expression in diabetic rat glomeruli and cultured rat mesangial cells
8. Role of cellular infiltrates in response to proteinuria
9. Activation of NF-κB in tubular epithelial cells of rats with intense proteinuria: Role of angiotensin II and endothelin-1
10. Effects of the 3-hydroxy-3-methyglutaryl-CoA reductase inhibitors, atorvastatin and simvastatin, on the expression of endothelin-1 and endothelial nitric oxide synthase in vascular endothelial cells
11. High prevalence of persistent cough with angiotensin converting enzyme inhibitors in Chinese
12. Microalbuminutia in a middle-aged workforce
13. A method for estimating nitrogen intake of patients with chronic renal failure
14. Preservation of glomerular filtration rate in human heart failure by activation of the renin-angiotensin system
15. Estrogen attenuates coronary vasoconstriction after angioplasty: Role of endothelin-1
16. Frozen storage of urine samples before ELISA measurement of retinol-binding protein
17. Urinary retinol binding protein: Stability and pre-analytical handling of specimens for its measurement
18. Enzymatic determination of total serum cholesterol
19. Sensitive assays for urinary retinol-binding protein and β-2-glycoprotein-1 based on commercially available standards
20. Amelioration of proteinuria with pravastatin in hypercholesterolemic patients with diabetes mellitus
21. Additive effects of simvastatin beyond its effects on LDL cholesterol in hypertensive type 2 diabetic patients
22. Partial remission of nephrotic syndrome in patients on long-term simvastatin
23. Proteinuria as complication of simvastatin treatment
24. Hypertensive nephrosclerosis as a relevant cause of chronic renal failure
25. Microalbuminuria and potential confounders: A review and some observations on variability of urinary albumin excretion
26. Effect of the HMG-CoA reductase inhibitors on blood pressure in patients with essential hypertension and primary hypercholesterolemia
27. Hemodynamic changes associated with reduction in total cholesterol by treatment with the HMG-CoA reductase inhibitor pravastatin
28. Lipid-lowering agents in proteinuric diseases
29. Cerivastatin prevents angiotensin II-induced renal injury independent of blood pressure- and cholesterol-lowering effects
30. Endothelins in the normal and diseased kidney
31. Tissue-selective uptake of pravastatin in rats: Contribution of a specific carrier-mediated uptake system
32. Pathophysiology of progressive nephropathies
33. Endothelin-1 transgenic mice develop glomerulosclerosis, interstitial fibrosis, and renal cysts but not hypertension
34. Retinol-binding protein and transferrin in urine. New markers of renal function in essential hypertension and white coat hypertension?
35. Distribution of angiotensin 2 receptor subtypes in rat and human kidney
36. Protein overload activates proximal tubular ells to release vasoactive and inflammatory mediators
37. Is the antiproteinuric effect of ACE inhibition mediated by interference in the renin-angiotensin system?
38. Renoprotective effect of contemporary blocking of angiotensin II and endothelin-1 in rats with membranous nephropathy